Eliminating new HIV transmissions by 2030 is a Scottish government and WHO target. Eliminating new transmissions requires a multi-pronged approach including HIV testing, early treatment of people newly diagnosed with HIV, and also prevention of HIV for those at on-going risk.
What is PrEP?
HIV Pre-exposure prophylaxis currently comes as a single tablet that contains 2 antiretrovirals – tenofovir disoproxil 245mg /emtricitabine 200mg. It can either be taken daily (daily PrEP) – at least 4 tablets taken per week in order to be effective, or event based PrEP, where 2 tablets are taken 2-24 hours prior to a potential exposure event, 1 tablet taken 24hs after the exposure and another 48hours after the exposure (4 tablets taken in total).
PrEP is provided as part of a package that also involves:
- Regular sexual history and risk assessment – usually every 3 months
- Regular screening for STI and blood borne infections (BBV) – usually every 3 month
- Regular renal monitoring – every 3-12months depending on patient age and co-morbidities
- Health promotion and prevention
- Condom provision
- Vaccination for HPV, Hepatitis B and Hepatitis A
More information can be found at
- NHS inform HIV PrEP (see resources)
- PrEP in Scotland (see resources)